BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37302338)

  • 1. Intermodal correlation of quantitative CT-data and MRI-biomarkers derived from synchronous spectral CT-maps and breast MRI-examinations with molecular biomarkers in invasive ductal breast carcinomas.
    Klein K; Gabriel Schafigh D; Schömig-Markiefka B; Campbell GM; Weiss K; Malter W; Maintz D; Hellmich M; Barbara Krug K
    Eur J Radiol; 2023 Aug; 165():110919. PubMed ID: 37302338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of CT-data derived from multiparametric dual-layer CT-maps with immunohistochemical biomarkers in invasive breast carcinomas.
    Barbara Krug K; Schömig-Markiefka B; Campbell GM; Püsken M; Maintz D; Schlamann M; Klein K; Gabriel Schafigh D; Malter W; Hellmich M
    Eur J Radiol; 2022 Nov; 156():110544. PubMed ID: 36219916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assignment of the biological value of solid breast masses based on quantitative evaluations of spectral CT examinations using electron density mapping, Zeffective mapping and iodine mapping.
    Klein K; Schafigh DG; Wallis MG; Campbell GM; Malter W; Schömig-Markiefka B; Maintz D; Hellmich M; Krug KB
    Eur J Radiol; 2024 Feb; 171():111280. PubMed ID: 38219351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer.
    Wang X; Liu D; Zeng X; Jiang S; Li L; Yu T; Zhang J
    Cancer Imaging; 2021 Jan; 21(1):4. PubMed ID: 33413654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possibility to discriminate benign from malignant breast lesions detected on dual-layer spectral CT-evaluation.
    Demirler Şimşir B; Krug KB; Burke C; Hellmich M; Maintz D; Coche E
    Eur J Radiol; 2021 Sep; 142():109832. PubMed ID: 34246013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Utility of Parameters Derived From Pretreatment Dual-Layer Spectral-Detector CT in Patients With Metastatic Renal Cell Carcinoma.
    Drljevic-Nielsen A; Donskov F; Mains JR; Andersen MB; Thorup K; Thygesen J; Rasmussen F
    AJR Am J Roentgenol; 2022 May; 218(5):867-876. PubMed ID: 34910540
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-Dose Perfusion Computed Tomography for Breast Cancer to Quantify Tumor Vascularity: Correlation With Prognostic Biomarkers.
    Park EK; Seo BK; Kwon M; Cho KR; Woo OH; Song SE; Cha J; Lee HY
    Invest Radiol; 2019 May; 54(5):273-281. PubMed ID: 30570503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-Energy CT for Locoregional Staging of Breast Cancer: Preliminary Results.
    Volterrani L; Gentili F; Fausto A; Pelini V; Megha T; Sardanelli F; Mazzei MA
    AJR Am J Roentgenol; 2020 Mar; 214(3):707-714. PubMed ID: 31939699
    [No Abstract]   [Full Text] [Related]  

  • 9. Opportunistic osteoporosis screening: contrast-enhanced dual-layer spectral CT provides accurate measurements of vertebral bone mineral density.
    Roski F; Hammel J; Mei K; Haller B; Baum T; Kirschke JS; Pfeiffer D; Woertler K; Pfeiffer F; Noël PB; Gersing AS; Schwaiger BJ
    Eur Radiol; 2021 May; 31(5):3147-3155. PubMed ID: 33052464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Quantitative Metrics From Dual-Layer Spectral-Detector CT for Differentiation of Pancreatic Neuroendocrine Tumor and Neuroendocrine Carcinoma.
    Wang Y; Hu X; Shi S; Song C; Wang L; Yuan J; Lin Z; Cai H; Feng ST; Luo Y
    AJR Am J Roentgenol; 2022 Jun; 218(6):999-1009. PubMed ID: 35043668
    [No Abstract]   [Full Text] [Related]  

  • 11. The diagnostic performance of dual-layer spectral detector CT for distinguishing breast cancer biomarker expression and molecular subtypes.
    Chen L; Xiao Z; Fu J; Huang J; Lan Y
    Sci Rep; 2024 Jan; 14(1):1500. PubMed ID: 38233452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.
    Fan M; Liu Z; Xie S; Xu M; Wang S; Gao X; Li L
    Phys Med Biol; 2019 Oct; 64(21):215001. PubMed ID: 31470420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements: are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional computed tomography perfusion?
    Stiller W; Skornitzke S; Fritz F; Klauss M; Hansen J; Pahn G; Grenacher L; Kauczor HU
    Invest Radiol; 2015 Oct; 50(10):703-8. PubMed ID: 26039774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
    Karan B; Pourbagher A; Torun N
    J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent diffusion coefficient in estrogen receptor-positive and lymph node-negative invasive breast cancers at 3.0T DW-MRI: A potential predictor for an oncotype Dx test recurrence score.
    Thakur SB; Durando M; Milans S; Cho GY; Gennaro L; Sutton EJ; Giri D; Morris EA
    J Magn Reson Imaging; 2018 Feb; 47(2):401-409. PubMed ID: 28640531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravoxel incoherent motion diffusion-weighted MRI of invasive breast cancer: Correlation with prognostic factors and kinetic features acquired with computer-aided diagnosis.
    Song SE; Cho KR; Seo BK; Woo OH; Park KH; Son YH; Grimm R
    J Magn Reson Imaging; 2019 Jan; 49(1):118-130. PubMed ID: 30238533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of contrast-enhanced CT, dual-layer detector spectral CT, and whole-body MRI in suspected metastatic breast cancer: a prospective diagnostic accuracy study.
    Buus TW; Rasmussen F; Nellemann HM; Løgager V; Jensen AB; Hauerslev KR; Christiansen P; Pedersen EM
    Eur Radiol; 2021 Dec; 31(12):8838-8849. PubMed ID: 34008104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated separation of diffusely abnormal white matter from focal white matter lesions on MRI in multiple sclerosis.
    Maranzano J; Dadar M; Zhernovaia M; Arnold DL; Collins DL; Narayanan S
    Neuroimage; 2020 Jun; 213():116690. PubMed ID: 32119987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction of prediction model combined dual-energy CT quantitative parameters and conventional CT features for assessing the Ki-67 expression levels in invasive breast cancer].
    Lin GH; Chen WY; Chen CM; Cheng X; Zhou BH; Ji JS
    Zhonghua Yi Xue Za Zhi; 2022 Jun; 102(23):1753-1759. PubMed ID: 35705479
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical feasibility of using effective atomic number maps derived from non-contrast spectral computed tomography to identify non-calcified atherosclerotic plaques: a preliminary study.
    Chen W; Li R; Yin K; Liang J; Li H; Chen X; Sheng Z; Yu H; Mu D
    Quant Imaging Med Surg; 2022 Apr; 12(4):2280-2287. PubMed ID: 35371951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.